Human Phenotype Ontology 
Grandparent Node:
expand
Weakness due to upper motor neuron dysfunction (HP:0010549)help
Parent Node:
expand
Hemiplegia/hemiparesis (HP:0004374)help
..Starting node
..expand
Hemiparesis (HP:0001269)help
Term ID: 1269
Name: Hemiparesis
Synonym: Weakness of one side of body
Definition: Loss of strength in the arm, leg, and sometimes face on one side of the body. Hemiplegia refers to a complete loss of strength, whereas hemiparesis refers to an incomplete loss of strength.
Comments:
Reference: HP:0001269
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandHemiplegia (HP:0002301) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0001269HP:0001269Hemiparesis0ABCD1 CL E G H21561ORPHA:139396X-linked cerebral adrenoleukodystrophyHP:0040283 - Occasional135
HP:0001269HP:0001269Hemiparesis0ADA2 CL E G H518161839ORPHA:820Sneddon syndromeHP:0040282 - Frequent22
HP:0001269HP:0001269Hemiparesis0AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040283 - Occasional54
HP:0001269HP:0001269Hemiparesis0AKT3 CL E G H10000393ORPHA:99802HemimegalencephalyHP:0040283 - Occasional19
HP:0001269HP:0001269Hemiparesis0AMACR CL E G H23600451OMIM:614307Alpha-methylacyl-CoA racemase deficiency44
HP:0001269HP:0001269Hemiparesis0ANGPTL6 CL E G H8385423140ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0ARHGAP31 CL E G H5751429216ORPHA:974Adams-Oliver syndromeHP:0040283 - Occasional147
HP:0001269HP:0001269Hemiparesis0ATP1A2 CL E G H477800ORPHA:569Familial or sporadic hemiplegic migraineHP:0040282 - Frequent239
HP:0001269HP:0001269Hemiparesis0ATP1A2 CL E G H477800OMIM:602481Migraine, familial hemiplegic, 2.239
HP:0001269HP:0001269Hemiparesis0ATP1A3 CL E G H478801OMIM:601338Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss.150
HP:0001269HP:0001269Hemiparesis0BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040283 - Occasional184
HP:0001269HP:0001269Hemiparesis0C4A CL E G H7201323ORPHA:117Behçet diseaseHP:0040282 - Frequent1
HP:0001269HP:0001269Hemiparesis0CACNA1A CL E G H7731388ORPHA:569Familial or sporadic hemiplegic migraineHP:0040282 - Frequent449
HP:0001269HP:0001269Hemiparesis0CACNA1A CL E G H7731388OMIM:141500Migraine, familial hemiplegic, 1.449
HP:0001269HP:0001269Hemiparesis0CCR1 CL E G H12301602ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0CFH CL E G H30754883OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.86
HP:0001269HP:0001269Hemiparesis0CFHR1 CL E G H30784888OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.
HP:0001269HP:0001269Hemiparesis0CFHR3 CL E G H1087816980OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.
HP:0001269HP:0001269Hemiparesis0COL3A1 CL E G H12812201ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent749
HP:0001269HP:0001269Hemiparesis0COL4A1 CL E G H12822202OMIM:175780Brain small vessel disease 1 with or without ocular anomalies.193
HP:0001269HP:0001269Hemiparesis0COX1 CL E G H45127419ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0COX1 CL E G H45127419OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0COX2 CL E G H45137421ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0COX2 CL E G H45137421OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0COX3 CL E G H45147422ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0COX3 CL E G H45147422OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0CYP26C1 CL E G H34066520577ORPHA:398189Focal facial dermal dysplasia type IVHP:0040282 - Frequent2
HP:0001269HP:0001269Hemiparesis0CYTB CL E G H45197427OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0DCC CL E G H16302701OMIM:617542GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 2; HGPPS236
HP:0001269HP:0001269Hemiparesis0DLL4 CL E G H545672910ORPHA:974Adams-Oliver syndromeHP:0040283 - Occasional9
HP:0001269HP:0001269Hemiparesis0DNM1L CL E G H100592973ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040284 - Very rare94
HP:0001269HP:0001269Hemiparesis0DOCK6 CL E G H5757219189ORPHA:974Adams-Oliver syndromeHP:0040283 - Occasional18
HP:0001269HP:0001269Hemiparesis0ENG CL E G H20223349ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent186
HP:0001269HP:0001269Hemiparesis0EOGT CL E G H28520328526ORPHA:974Adams-Oliver syndromeHP:0040283 - Occasional4
HP:0001269HP:0001269Hemiparesis0ERAP1 CL E G H5175218173ORPHA:117Behçet diseaseHP:0040282 - Frequent1
HP:0001269HP:0001269Hemiparesis0FAS CL E G H35511920ORPHA:117Behçet diseaseHP:0040282 - Frequent59
HP:0001269HP:0001269Hemiparesis0FGFR1 CL E G H22603688ORPHA:2396Encephalocraniocutaneous lipomatosisHP:0040283 - Occasional172
HP:0001269HP:0001269Hemiparesis0GBE1 CL E G H26324180ORPHA:206583Adult polyglucosan body diseaseHP:0040281 - Very frequent86
HP:0001269HP:0001269Hemiparesis0GNAQ CL E G H27764390ORPHA:624Familial multiple nevi flammeiHP:0040283 - Occasional7
HP:0001269HP:0001269Hemiparesis0GUCY1A1 CL E G H29824685OMIM:615750Moyamoya disease 6 with achalasiaHP:0040283 - Occasional
HP:0001269HP:0001269Hemiparesis0HLA-B CL E G H31064932ORPHA:117Behçet diseaseHP:0040282 - Frequent4
HP:0001269HP:0001269Hemiparesis0HLA-DQB1 CL E G H31194944OMIM:123400Creutzfeldt-Jakob disease.
HP:0001269HP:0001269Hemiparesis0HMGCL CL E G H31555005ORPHA:203-hydroxy-3-methylglutaric aciduria35
HP:0001269HP:0001269Hemiparesis0HRAS CL E G H32655173ORPHA:2874Phakomatosis pigmentokeratotica113
HP:0001269HP:0001269Hemiparesis0HTRA1 CL E G H56549476ORPHA:199354Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy34
HP:0001269HP:0001269Hemiparesis0IFNGR1 CL E G H34595439ORPHA:117Behçet diseaseHP:0040282 - Frequent60
HP:0001269HP:0001269Hemiparesis0IL10 CL E G H35865962ORPHA:117Behçet diseaseHP:0040282 - Frequent2
HP:0001269HP:0001269Hemiparesis0IL12A CL E G H35925969ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0IL12A-AS1 CL E G H10192837649094ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0IL23R CL E G H14923319100ORPHA:117Behçet diseaseHP:0040282 - Frequent1
HP:0001269HP:0001269Hemiparesis0KLRC4 CL E G H83026377ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0KRAS CL E G H38456407ORPHA:2396Encephalocraniocutaneous lipomatosisHP:0040283 - Occasional196
HP:0001269HP:0001269Hemiparesis0MEFV CL E G H42106998ORPHA:117Behçet diseaseHP:0040282 - Frequent281
HP:0001269HP:0001269Hemiparesis0MTHFR CL E G H45247436ORPHA:395Homocystinuria due to methylene tetrahydrofolate reductase deficiencyHP:0040283 - Occasional183
HP:0001269HP:0001269Hemiparesis0MTOR CL E G H24753942OMIM:607341Focal cortical dysplasia of taylor.68
HP:0001269HP:0001269Hemiparesis0MTOR CL E G H24753942ORPHA:99802HemimegalencephalyHP:0040283 - Occasional68
HP:0001269HP:0001269Hemiparesis0ND1 CL E G H45357455ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0ND1 CL E G H45357455OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0ND4 CL E G H45387459ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0ND5 CL E G H45407461ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0ND5 CL E G H45407461OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0ND6 CL E G H45417462ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0ND6 CL E G H45417462OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040283 - Occasional220
HP:0001269HP:0001269Hemiparesis0NF2 CL E G H47717773ORPHA:637Neurofibromatosis type 2HP:0040283 - Occasional220
HP:0001269HP:0001269Hemiparesis0NOTCH1 CL E G H48517881ORPHA:974Adams-Oliver syndromeHP:0040283 - Occasional452
HP:0001269HP:0001269Hemiparesis0NOTCH3 CL E G H48547883OMIM:125310Cerebral arteriopathy, autosomal dominant, with subcortical infarctsand leukoencephalopathy144
HP:0001269HP:0001269Hemiparesis0OPA1 CL E G H49768140ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040284 - Very rare214
HP:0001269HP:0001269Hemiparesis0PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040283 - Occasional9
HP:0001269HP:0001269Hemiparesis0PIK3CA CL E G H52908975ORPHA:99802HemimegalencephalyHP:0040283 - Occasional162
HP:0001269HP:0001269Hemiparesis0PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040283 - Occasional162
HP:0001269HP:0001269Hemiparesis0PLA2G6 CL E G H83989039OMIM:612953Parkinson disease 14, autosomal recessive133
HP:0001269HP:0001269Hemiparesis0PNPLA8 CL E G H5064028900OMIM:251950Mitochondrial myopathy with lactic acidosis.3
HP:0001269HP:0001269Hemiparesis0PRNP CL E G H56219449OMIM:123400Creutzfeldt-Jakob disease.69
HP:0001269HP:0001269Hemiparesis0PRNP CL E G H56219449ORPHA:282166Inherited Creutzfeldt-Jakob disease69
HP:0001269HP:0001269Hemiparesis0PRORP CL E G H969219958OMIM:619737COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54; COXPD54
HP:0001269HP:0001269Hemiparesis0PRRT2 CL E G H11247630500ORPHA:569Familial or sporadic hemiplegic migraineHP:0040282 - Frequent94
HP:0001269HP:0001269Hemiparesis0RBPJ CL E G H35165724ORPHA:974Adams-Oliver syndromeHP:0040283 - Occasional3
HP:0001269HP:0001269Hemiparesis0RHOBTB2 CL E G H2322118756OMIM:618004Epileptic encephalopathy, early infantile, 64.1
HP:0001269HP:0001269Hemiparesis0SCN1A CL E G H632310585ORPHA:569Familial or sporadic hemiplegic migraineHP:0040282 - Frequent1053
HP:0001269HP:0001269Hemiparesis0SCN1A CL E G H632310585OMIM:609634Migraine, familial hemiplegic, 3.1053
HP:0001269HP:0001269Hemiparesis0SLC1A3 CL E G H650710941OMIM:612656Episodic ataxia, type 6.63
HP:0001269HP:0001269Hemiparesis0SLC2A1 CL E G H651311005ORPHA:71277Classic glucose transporter type 1 deficiency syndromeHP:0040282 - Frequent255
HP:0001269HP:0001269Hemiparesis0SLC2A1 CL E G H651311005OMIM:606777Glut1 deficiency syndrome 1.255
HP:0001269HP:0001269Hemiparesis0SMARCAL1 CL E G H5048511102ORPHA:1830Schimke immuno-osseous dysplasiaHP:0040283 - Occasional74
HP:0001269HP:0001269Hemiparesis0SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040283 - Occasional87
HP:0001269HP:0001269Hemiparesis0SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040283 - Occasional47
HP:0001269HP:0001269Hemiparesis0SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040283 - Occasional22
HP:0001269HP:0001269Hemiparesis0SP110 CL E G H34315401ORPHA:79124Hepatic veno-occlusive disease-immunodeficiency syndromeHP:0040283 - Occasional49
HP:0001269HP:0001269Hemiparesis0SPATA5L1 CL E G H7902928762OMIM:619616NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS
HP:0001269HP:0001269Hemiparesis0SPOP CL E G H840511254OMIM:618829NABAIS SA-DE VRIES SYNDROME, TYPE 2; NSDVS216
HP:0001269HP:0001269Hemiparesis0STAT4 CL E G H677511365ORPHA:117Behçet diseaseHP:0040282 - Frequent2
HP:0001269HP:0001269Hemiparesis0SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040283 - Occasional124
HP:0001269HP:0001269Hemiparesis0TBC1D24 CL E G H5746529203OMIM:615338Epileptic encephalopathy, early infantile, 16.271
HP:0001269HP:0001269Hemiparesis0TBC1D24 CL E G H5746529203ORPHA:352596Progressive myoclonic epilepsy with dystoniaHP:0040283 - Occasional271
HP:0001269HP:0001269Hemiparesis0TBK1 CL E G H2911011584OMIM:617900Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8.20
HP:0001269HP:0001269Hemiparesis0TBX1 CL E G H689911592OMIM:188400Digeorge syndrome32
HP:0001269HP:0001269Hemiparesis0TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040283 - Occasional238
HP:0001269HP:0001269Hemiparesis0TGFBR3 CL E G H704911774ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent1
HP:0001269HP:0001269Hemiparesis0THSD1 CL E G H5590117754ORPHA:231160Familial cerebral saccular aneurysmHP:0040282 - Frequent2
HP:0001269HP:0001269Hemiparesis0TLR3 CL E G H709811849OMIM:613002Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2HP:0040284 - Very rare3
HP:0001269HP:0001269Hemiparesis0TLR4 CL E G H709911850ORPHA:117Behçet diseaseHP:0040282 - Frequent3
HP:0001269HP:0001269Hemiparesis0TPP2 CL E G H717412016ORPHA:444463Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndromeHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040283 - Occasional
HP:0001269HP:0001269Hemiparesis0TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHP:0040283 - Occasional56
HP:0001269HP:0001269Hemiparesis0TREX1 CL E G H1127712269OMIM:192315Vasculopathy, retinal, with cerebral leukodystrophy.56
HP:0001269HP:0001269Hemiparesis0TRNC CL E G H45117477OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TRNF CL E G H45587481ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0TRNF CL E G H45587481OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TRNH CL E G H45647487ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0TRNK CL E G H45667489OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TRNL1 CL E G H45677490ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0TRNL1 CL E G H45677490OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TRNQ CL E G H45727495ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0TRNQ CL E G H45727495OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TRNS1 CL E G H45747497ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0TRNS1 CL E G H45747497OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TRNS2 CL E G H45757498ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0TRNS2 CL E G H45757498OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TRNV CL E G H45777500OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TRNW CL E G H45787501ORPHA:550MELASHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0TRNW CL E G H45787501OMIM:540000Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
HP:0001269HP:0001269Hemiparesis0TSC1 CL E G H724812362OMIM:607341Focal cortical dysplasia of taylor.1090
HP:0001269HP:0001269Hemiparesis0TSC2 CL E G H724912363OMIM:607341Focal cortical dysplasia of taylor.2738
HP:0001269HP:0001269Hemiparesis0TTR CL E G H727612405OMIM:105210Amyloidosis, hereditary, transthyretin-related.107
HP:0001269HP:0001269Hemiparesis0TUBB2B CL E G H34773330829OMIM:610031Cortical dysplasia, complex, with other brain malformations 7.39
HP:0001269HP:0001269Hemiparesis0TUBB2B CL E G H34773330829ORPHA:300573Polymicrogyria due to TUBB2B mutationHP:0040282 - Frequent39
HP:0001269HP:0001269Hemiparesis0UBAC2 CL E G H33786720486ORPHA:117Behçet diseaseHP:0040282 - Frequent
HP:0001269HP:0001269Hemiparesis0WDR62 CL E G H28440324502OMIM:604317Microcephaly 2, primary, autosomal recessive, with or without cortical malformations.224
HP:0001269HP:0011099Spastic hemiparesis1HMGCL CL E G H31555005ORPHA:203-hydroxy-3-methylglutaric aciduriaHP:0040284 - Very rare35
HP:0001269HP:0011099Spastic hemiparesis1PRNP CL E G H56219449ORPHA:282166Inherited Creutzfeldt-Jakob diseaseHP:0040282 - Frequent69
HP:0001269HP:0011099Spastic hemiparesis1SPATA5L1 CL E G H7902928762OMIM:619616NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS


Genes (106) :ABCD1 ADA2 AKT1 AKT3 AMACR ANGPTL6 ARHGAP31 ATP1A2 ATP1A3 BAP1 C4A CACNA1A CCR1 CFH CFHR1 CFHR3 COL3A1 COL4A1 COX1 COX2 COX3 CYP26C1 CYTB DCC DLL4 DNM1L DOCK6 ENG EOGT ERAP1 FAS FGFR1 GBE1 GNAQ GUCY1A1 HLA-B HLA-DQB1 HMGCL HRAS HTRA1 IFNGR1 IL10 IL12A IL12A-AS1 IL23R KLRC4 KRAS MEFV MTHFR MTOR ND1 ND4 ND5 ND6 NF2 NOTCH1 NOTCH3 OPA1 PDGFB PIK3CA PLA2G6 PNPLA8 PRNP PRORP PRRT2 RBPJ RHOBTB2 SCN1A SLC1A3 SLC2A1 SMARCAL1 SMARCB1 SMARCE1 SMO SP110 SPATA5L1 SPOP STAT4 SUFU TBC1D24 TBK1 TBX1 TERT TGFBR3 THSD1 TLR3 TLR4 TPP2 TRAF7 TREX1 TRNC TRNF TRNH TRNK TRNL1 TRNQ TRNS1 TRNS2 TRNV TRNW TSC1 TSC2 TTR TUBB2B UBAC2 WDR62

Diseases (56) :ORPHA:139396 ORPHA:820 ORPHA:2495 ORPHA:99802 OMIM:614307 ORPHA:231160 ORPHA:974 ORPHA:569 OMIM:602481 OMIM:601338 ORPHA:117 OMIM:141500 OMIM:235400 OMIM:175780 ORPHA:550 OMIM:540000 ORPHA:398189 OMIM:617542 ORPHA:98673 ORPHA:2396 ORPHA:206583 ORPHA:624 OMIM:615750 OMIM:123400 ORPHA:20 ORPHA:2874 ORPHA:199354 ORPHA:395 OMIM:607341 ORPHA:637 OMIM:125310 OMIM:612953 OMIM:251950 ORPHA:282166 OMIM:619737 OMIM:618004 OMIM:609634 OMIM:612656 ORPHA:71277 OMIM:606777 ORPHA:1830 ORPHA:79124 OMIM:619616 OMIM:618829 OMIM:615338 ORPHA:352596 OMIM:617900 OMIM:188400 OMIM:613002 ORPHA:444463 ORPHA:247691 OMIM:192315 OMIM:105210 OMIM:610031 ORPHA:300573 OMIM:604317
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.